Ignite Creation Date:
2024-05-05 @ 11:55 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00171184
Status:
COMPLETED
Last Update Posted:
2017-05-18
First Post:
2005-09-12
Brief Title:
Efficacy Safety and Tolerability of Darifenacin in Patients Aged 65 Years With Overactive Bladder
Sponsor:
Novartis
Organization:
Novartis
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Overactive Bladder |
Keywords:
| Name | View |
|---|---|
| Overactive bladder Darifenacin M3 muscarinic receptor antagonist elderly population | View |